c-Reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 483-489

  Lao, X Q ^a,b   Thomas, G Neil ^a   Jiang, C Q ^b   Zhang, W S ^b   Yin, P ^c   Adab, Peymane ^c   Lam, Tai Hing ^a   Cheng, K K ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Guangzhou Number 12 Hospital   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

c Reactive protein; Chinese; Metabolic syndrome; Vascular risk factors

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHINA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 34848907103     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.061     Document Type: Article

References (29)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
3. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
4. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104 (2001) 145-150
5. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
6. Strandberg T.E., and Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20 (2000) 1057-1060
7. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
8. Ford E.S. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168 (2003) 351-358
9. Tamakoshi K., Yatsuya H., Kondo T., et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27 (2003) 443-449
10. Festa A., D'Agostino Jr. R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
11. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 (2000) 1835-1839
12. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
13. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome (2005), International Diabetes Federation. http://www.idf.org/ http://www.idf.org (accessed September, 2005)
14. International Physical Activity Questionnaire. http://wwwipaqkise/ (last accessed December 15, 2005).
15. Baudner S., Bienvenu J., Bilrup-Jensen S., et al. The certification of a matrix reference material for immunochemical measurement of 14 human serum proteins. CRM470 (1993), Community of Bureau of Reference, Commission of the European Communities, Brussels p. 1-172
16. Bazzano L.A., He J., Muntner P., Vupputuri S., and Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 138 (2003) 891-897
17. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., and Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89 (2002) 1117-1119
18. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (1996) 1061-1065
19. Danesh J., Muir J., Wong Y.K., et al. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 20 (1999) 954-959
20. Timpson N.J., Lawlor D.A., Harbord R.M., et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 366 (2005) 1954-1959
21. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
22. Folsom A.R., Pankow J.S., Tracy R.P., et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88 (2001) 112-117
23. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
24. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
25. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
26. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
27. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
28. Thomas G.N., Ho S.Y., Lam K.S., et al. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 12 (2004) 1805-1813
29. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 102 (2000) 179-184